✦ LIBER ✦

Specific Hepatitis B Vaccine Therapy in Inactive HBsAg Carriers: A Randomized Controlled Trial

✍ Scribed by K. Yalcin; M. Acar; H. Degertekin

Book ID: 107705218
Publisher: Springer-Verlag
Year: 2003
Tongue: English
Weight: 240 KB
Volume: 31
Category: Article
ISSN: 0300-8126
DOI: 10.1007/s15010-003-3187-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatitis B vaccination in haemodialysis

Hepatitis B vaccination in haemodialysis patients: A randomized clinical trial

✍ MARILENE BOCK; ELVINO BARROS; FRANCISCO JV VERONESE 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

A randomized controlled trial of high-do

A randomized controlled trial of high-dose maintenance interferon therapy in chronic hepatitis C

✍ Di Marco, Vito; Lo Iacono, Oreste; Cammà, Calogero; Almasio, Piero L.; Vaccaro, 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 2 views

In chronic hepatitis C virus (HCV) infection, the rate of sustained response to interferon is low. We evaluated, in patients responding to a 26-week course of interferon, the effect of high-dose maintenance therapy in preventing relapse. Three hundred and ten patients with chronic HCV infection (38.

Lamivudine is effective in suppressing h

Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: A placebo-controlled trial

✍ C. Lai; C. Ching; A. K. Tung; E. Li; J. Young; A. Hill; B. C. Wong; J. Dent; P. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 1 views

Interferon-α and zidovudine combination

Interferon-α and zidovudine combination therapy for chronic hepatitis B: Results of a randomized, placebo-controlled trial

✍ Harry L. A. Janssen; Luuk Berk; Rudolf A. Heijtink; Fiebo J. W. Ten Kate; Solko 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 630 KB

Interferon-a therapy leads to HBeAg seroconversion in only one third of patients with chronic hepatitis B. In an attempt to increase the seroconversion rate, we investigated the combination of interferon-a and zidovudine in a subset of patients with presumably low response rates for interferon-a mon

Efficacy of thymosin α1 in patients with

Efficacy of thymosin α1 in patients with chronic hepatitis B: A randomized, controlled trial

✍ Rong-Nan Chien; Yun-Fan Liaw; Tse-Ching Chen; Chau-Ting Yeh; I.-Shyan Sheen 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 1 views

Thymosin ␣ 1 (T␣) is an immune modifier that has been shown in a pilot study to be effective for chronic hepatitis B; this requires confirmation. Ninety-eight patients with clinicopathologically proven chronic hepatitis B were randomly allocated to 3 groups: 1) group A received a 26-week course of T

Randomized double blind placebo-controll

Randomized double blind placebo-controlled trial of a Chinese herbal therapy (CH100) in chronic hepatitis C

✍ Lindsay Mollison; Leanne Totten; James Flexman; Miles Beaman; Robert Batey 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB